Atatürk Training and Research Hospital, Clinic of Endocrinology and Metabolism, Ankara, Turkey
Berna Öğmen
Atatürk Training and Research Hospital, Clinic of Endocrinology and Metabolism, Ankara, Turkey
Cihan Doğer
Atatürk Training and Research Hospital, Clinic of Anesthesiology, Ankara, Turkey
Burçak Polat
Atatürk Training and Research Hospital, Clinic of Endocrinology and Metabolism, Ankara, Turkey
Seval İzdeş
Atatürk Training and Research Hospital, Clinic of Anesthesiology, Ankara, Turkey
Reyhan Ersoy
Atatürk Training and Research Hospital, Clinic of Endocrinology and Metabolism, Ankara, Turkey
Bekir Çakır
Atatürk Training and Research Hospital, Clinic of Endocrinology and Metabolism, Ankara, Turkey
Çuhacı, N., Öğmen, B., Doğer, C., Polat, B., İzdeş, S., Ersoy, R., & Çakır, B. (2017). Association of Hormonal Changes with Disease Severity and Mortality in Critically-ill Patients. Endocrinology Research and Practice, 21(1), 1–8. https://doi.org/10.4274/tjem.3498
Purpose: Endocrine and metabolic changes, which may affect the prognosis and outcome, can occur in critically ill patients. In this prospective study, we aimed to evaluate the changes in the pituitary-adrenal-gonadal-thyroid axis in patients admitted to the adult intensive care unit on admission and 15 days later and also to evaluate whether these hormonal changes contribute to prognosis and mortality as well as to investigate the association between these hormonal changes and Acute Physiology and Chronic Health Evaluation II (APACHE II) and sequential organ failure assessment (SOFA) scores, length of hospitalization, and mortality. Material and Method: One hundred and fifty seven patients were enrolled in this study. Severity of illness was assessed by APACHE II and SOFA scores. Blood samples were collected within the first 4 hours of intensive care unit admission and 15 days later for hormonal evaluation. Results: Eighty-five patients were in survival (S), 72 were in the non-survival (NS) group. The median age, and baseline APACHE II, median APACHE II mortality and SOFA scores in NS group were significantly higher than in S group. According the baseline endocrine parameters, the predictive factors on mortality were age, baseline SOFA score and hospitalization length and also, 15 days after the admission, age and Δ TSH were found be the predictive factors in mortality. Discussion: Our study revealed that none of the endocrine parameters contribute to mortality except Δ TSH. We assume that Δ TSH can be used together with APACHE II or SOFA scores in the prediction of prognosis in a tertiary mixed type intensive care unit.
Copyright (c) 2017 Endocrinology Research and Practice
Affiliations
Neslihan Çuhacı
Atatürk Training and Research Hospital, Clinic of Endocrinology and Metabolism, Ankara, Turkey
Berna Öğmen
Atatürk Training and Research Hospital, Clinic of Endocrinology and Metabolism, Ankara, Turkey
Cihan Doğer
Atatürk Training and Research Hospital, Clinic of Anesthesiology, Ankara, Turkey
Burçak Polat
Atatürk Training and Research Hospital, Clinic of Endocrinology and Metabolism, Ankara, Turkey
Seval İzdeş
Atatürk Training and Research Hospital, Clinic of Anesthesiology, Ankara, Turkey
Reyhan Ersoy
Atatürk Training and Research Hospital, Clinic of Endocrinology and Metabolism, Ankara, Turkey
Bekir Çakır
Atatürk Training and Research Hospital, Clinic of Endocrinology and Metabolism, Ankara, Turkey
Cite this Article
Çuhacı, N., Öğmen, B., Doğer, C., Polat, B., İzdeş, S., Ersoy, R., & Çakır, B. (2017). Association of Hormonal Changes with Disease Severity and Mortality in Critically-ill Patients. Endocrinology Research and Practice, 21(1), 1–8. https://doi.org/10.4274/tjem.3498